Lawsuits Over the Price of Insulin

This Viewpoint discusses the litigation strategy of state-initiated lawsuits alleging illegal and immoral conduct regarding the pricing of insulin by pharmaceutical companies and pharmacy benefit managers.

from JAMA Internal Medicine Online First https://ift.tt/aMmQ65g